S4 Medical Corp.

CHAGRIN FALLS, OH · Founded 2021 · Medtech · Private

FDA-cleared esophageal protection device that deviates the esophagus during cardiac ablation procedures

Claim this profile

Follows are private to you and power your alerts

Updated · s4medical.com

Sector
Medtech
Headquarters
CHAGRIN FALLS, OH
Founded
2021
Latest Form D
$5.8M, Jul 2023
Total capital
$9.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$9.5M
3 Form D · last Jul 2023
40 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
2 pending · first 2022
Rank in peer group#370 of 1112

Capital timeline

202120222023FEDERAL ↑EQUITY ↓Cumulative $9.5M1st Form D$3M2nd Form D$746K3rd Form D$5.8M
202120222023FEDERAL ↑EQUITY ↓Cumulative $9.5M1st Form D$3M2nd Form D$746K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$5.8M
  • Private capital raisedForm D · SEC · 2nd filing$746K
  • Private capital raisedForm D · SEC · 1st filing$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Emile DaoudResearcherExecutive Officer, DirectorLinked by 3 patents
  • Anila LingamneniDirectorNamed in SEC Form D filings
  • Bill BaumelDirectorNamed in SEC Form D filings
  • Emile DaodExecutive Officer, DirectorNamed in SEC Form D filings
  • Hirak ParikhDirectorNamed in SEC Form D filings
  • Roy TanakaDirectorNamed in SEC Form D filings
Show all 7 people
  • William FullerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 5
Show all 5 patent records
  • healthOme, Inc.Similar federal contract value in Medtech · null in contracts
  • Gestalt Diagnostics, Inc.Similar federal contract value in Medtech · null in contracts
  • Illumigyn Ltd.Similar federal contract value in Medtech · null in contracts
  • LeukoDx, Inc.Similar federal contract value in Medtech · null in contracts
  • CURE PHARMACEUTICAL CorpSimilar federal contract value in Medtech · null in contracts
  • Vivex Biomedical, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .